Highlander Capital Management Maintains Stake in Oracle (ORCL); Peak Asset Management Has Upped Holding in Gilead Sciences (GILD) by $5.23 Million as Shares Rose

May 27, 2018 - By Ash

Oracle Corporation (NYSE:ORCL) Logo

Highlander Capital Management Llc increased its stake in Oracle Corporation (ORCL) by 63.97% based on its latest 2017Q4 regulatory filing with the SEC. Highlander Capital Management Llc bought 6,900 shares as the company’s stock declined 4.18% with the market. The institutional investor held 17,687 shares of the prepackaged software company at the end of 2017Q4, valued at $836,000, up from 10,787 at the end of the previous reported quarter. Highlander Capital Management Llc who had been investing in Oracle Corporation for a number of months, seems to be bullish on the $191.87B market cap company. The stock increased 1.16% or $0.54 during the last trading session, reaching $47. About 11.35 million shares traded. Oracle Corporation (NYSE:ORCL) has risen 1.20% since May 27, 2017 and is uptrending. It has underperformed by 10.35% the S&P500.

Peak Asset Management Llc increased its stake in Gilead Sciences Inc (GILD) by 73691% based on its latest 2017Q4 regulatory filing with the SEC. Peak Asset Management Llc bought 73,691 shares as the company’s stock rose 1.93% while stock markets declined. The hedge fund held 73,791 shares of the health care company at the end of 2017Q4, valued at $5.29 million, up from 100 at the end of the previous reported quarter. Peak Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $87.61 billion market cap company. The stock decreased 0.22% or $0.15 during the last trading session, reaching $67.38. About 3.96 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 27, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Peak Asset Management Llc, which manages about $326.42M and $273.45 million US Long portfolio, decreased its stake in Ishares Tr (IJR) by 13,012 shares to 5,722 shares, valued at $440,000 in 2017Q4, according to the filing. It also reduced its holding in Berkshire Hathaway Inc Del (BRKB) by 2,745 shares in the quarter, leaving it with 36,040 shares, and cut its stake in Raytheon Co (NYSE:RTN).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, February 6 by Maxim Group. The firm has “Buy” rating by Berenberg given on Monday, September 12. The company was upgraded on Wednesday, November 2 by BMO Capital Markets. As per Friday, February 5, the company rating was initiated by Leerink Swann. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Wednesday, May 2 by RBC Capital Markets. The rating was upgraded by Bank of America to “Neutral” on Friday, January 15. Bank of America maintained the shares of GILD in report on Wednesday, February 7 with “Neutral” rating. The company was initiated on Friday, December 18 by Atlantic Securities. The stock has “Hold” rating by Argus Research on Monday, November 13. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Argus Research on Friday, July 29.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Field & Main National Bank & Trust accumulated 3,650 shares or 0.25% of the stock. Moreover, Coastline has 0.12% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Private Asset Inc accumulated 1.5% or 131,279 shares. Hexavest reported 0.39% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Paradigm Advsr Ltd Company owns 4,947 shares. Whitnell holds 2,400 shares. Calamos Ltd Liability Corporation has invested 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD). Intrust Bank & Trust Na has 17,603 shares for 0.38% of their portfolio. Mariner Wealth Advsrs Limited Liability Corp accumulated 24,899 shares. Ipswich Investment Management accumulated 8,566 shares or 0.26% of the stock. Moreover, Dupont Cap Mngmt has 0.07% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Chevy Chase Inc holds 0.35% in Gilead Sciences, Inc. (NASDAQ:GILD) or 1.14M shares. Wells Fargo And Company Mn owns 11.17M shares or 0.23% of their US portfolio. Tudor Corporation Et Al reported 3,947 shares. Blume Mgmt Inc invested in 4,250 shares or 0.16% of the stock.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: 247Wallst.com which released: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” on May 02, 2018, also 247Wallst.com with their article: “Will Gilead Sciences Earnings Get a Boost From a Collaboration?” published on May 01, 2018, 247Wallst.com published: “Short Interest Remains Mixed in Major Biotechs” on May 25, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “AbbVie’s Mavyret Could Punish Gilead Tuesday” published on April 30, 2018 as well as Seekingalpha.com‘s news article titled: “Lipotoxicity And NASH: Gilead’s Actions Speak Louder Than Words” with publication date: May 09, 2018.

Since January 2, 2018, it had 0 insider buys, and 22 selling transactions for $44.80 million activity. On Monday, April 2 the insider Cogan John Francis sold $437,067. Shares for $3.66M were sold by MARTIN JOHN C. Meyers James R had sold 100,000 shares worth $8.02M. 60,000 shares were sold by WILSON GAYLE E, worth $4.68M on Friday, February 9. Washington Robin L sold $401,566 worth of stock or 5,000 shares.

Among 43 analysts covering Oracle (NYSE:ORCL), 27 have Buy rating, 0 Sell and 16 Hold. Therefore 63% are positive. Oracle had 116 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Oracle Corporation (NYSE:ORCL) earned “Outperform” rating by Cowen & Co on Friday, June 24. The firm has “Hold” rating by Wunderlich given on Thursday, September 17. The stock of Oracle Corporation (NYSE:ORCL) earned “Buy” rating by Jefferies on Monday, July 24. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, March 15 report. RBC Capital Markets maintained Oracle Corporation (NYSE:ORCL) rating on Thursday, December 17. RBC Capital Markets has “Outperform” rating and $46 target. Nomura maintained it with “Buy” rating and $44 target in Thursday, September 17 report. The stock of Oracle Corporation (NYSE:ORCL) earned “Outperform” rating by Wells Fargo on Wednesday, January 11. The rating was maintained by Goldman Sachs with “Buy” on Wednesday, March 16. The stock has “Buy” rating by Jefferies on Friday, September 15. The firm has “Buy” rating by UBS given on Thursday, November 9.

Highlander Capital Management Llc, which manages about $131.70M and $136.75 million US Long portfolio, decreased its stake in Bristol Myers Squibb Co (NYSE:BMY) by 11,450 shares to 5,424 shares, valued at $332,000 in 2017Q4, according to the filing. It also reduced its holding in Foot Locker Inc (NYSE:FL) by 8,150 shares in the quarter, leaving it with 1,850 shares, and cut its stake in Calgon Carbon Corp (NYSE:CCC).

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.02, from 1.13 in 2017Q3. It is positive, as 80 investors sold ORCL shares while 488 reduced holdings. 126 funds opened positions while 526 raised stakes. 2.29 billion shares or 1.37% less from 2.32 billion shares in 2017Q3 were reported. Pacad invested 0.45% of its portfolio in Oracle Corporation (NYSE:ORCL). Convergence Inv Prns Limited Co reported 91,051 shares. Country Tru Natl Bank owns 894,427 shares or 1.82% of their US portfolio. Karpus Management Inc has invested 0.01% in Oracle Corporation (NYSE:ORCL). Beaumont Financial Prns Ltd Liability Company holds 0.24% or 43,180 shares in its portfolio. East Coast Asset Mngmt Limited Liability Co reported 4,247 shares stake. Brave Asset Management, a New Jersey-based fund reported 16,574 shares. Boston Prtn invested in 1.36% or 24.38 million shares. Renaissance Technology Limited stated it has 5.15 million shares or 0.27% of all its holdings. Raymond James Assocs reported 3.79M shares. Ally Fin invested in 105,000 shares. 191,624 were accumulated by Highland Cap Ltd Limited Liability Company. Motley Fool Wealth Ltd Liability Co owns 122,141 shares for 0.44% of their portfolio. Cap Invest Counsel owns 58,188 shares for 1.14% of their portfolio. Bragg Advsrs has 184,599 shares.

More notable recent Oracle Corporation (NYSE:ORCL) news were published by: Seekingalpha.com which released: “Oracle To Acquire DataScience For Workflow Technologies” on May 22, 2018, also Seekingalpha.com with their article: “What Does Cap Ex Spending Tell Us About Oracle’s Future Cloud Growth?” published on May 23, 2018, Fool.com published: “Better Buy: International Business Machines (IBM) vs. Oracle (ORCL)” on May 09, 2018. More interesting news about Oracle Corporation (NYSE:ORCL) were released by: Seekingalpha.com and their article: “The Information: Oracle’s aggressive cloud sales tactics push away customers” published on May 22, 2018 as well as Profitconfidential.com‘s news article titled: “Cloudera Stock: Battered Cloud Data Play Rallying After Oversold Selling” with publication date: May 27, 2018.

Oracle Corporation (NYSE:ORCL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ash

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: